No-Needle lactate test: mayo clinic trial pulled before start
NCT ID NCT05036122
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aimed to test a device called LabClasp that estimates blood lactate levels without a needle, using fluid from the skin. It was designed for healthy people during exercise and for ICU patients. However, the trial was withdrawn before any volunteers were enrolled, so no results are available.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- LabClasp device
- What this could lead to
- If validated, this device could allow quick, needle-free lactate monitoring during exercise or in ICU patients.
- What could go wrong
- The study was withdrawn before enrolling any participants, so no data exists. The device's accuracy and reliability remain unproven.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug change future treatments? early safety trial begins
- Can brain scans unlock the secret to hearing in crowded rooms?
- Can a Light-Guided device make arterial sticks easier?
- Water workouts could be the key to back pain relief
- Could everyday disinfectants be harming us? a new study investigates
- Can a new drug keep the Heart's beat steady? trial puts verducatib to the test